Moreover, TRIM28 has been demonstrated to regulate EMT gene expression (CDH1 encoding E-CADHERIN and CDH2 encoding N-CADHERIN) through modification of histones of target gene promoters, further implying its role in acquisition of highly aggressive mesenchymal phenotype of cancer cells [74]. The gene discussed is CDH2; the disease is cancer.